COMPANY
CHANGZHOU PHARMACEUTICAL FACTORY
CHANGZHOU PHARMACEUTICAL FACTORY: API manufacturer for Semaglutide, Tirzepatide, as stated by public registers.
API MANUFACTURER
Filed a drug master file with FDA for the active ingredient.
| Semaglutide | DMF 42883, type II, active, submitted 2025-10-29 Regulator FDA drug master file list |
|---|---|
| Tirzepatide | DMF 43153, type II, active, submitted 2025-11-28 Regulator FDA drug master file list |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.